Skip to main content

New Products: Qiagen's Ingenuity Interpretation System

Premium

Qiagen has begun enrolling molecular diagnostics laboratories in an early access program for its web-based clinical interpretation tool for next-generation sequencing tests. The tool makes use of its Ingenuity Knowledge Base database and will provide labs with automated scoring, interpretation, and reporting of findings in standardized, HIPAA Safe Harbor-compliant formats, according to the company. The early access members include Emory Genetics Laboratory, GeneDx, LabCorp, Partners Healthcare, and Quest Diagnostics.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.